{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T17:35:34Z","timestamp":1786642534852,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:00:00Z","timestamp":1778284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:00:00Z","timestamp":1778284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00774-026-01732-0","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T08:33:05Z","timestamp":1778315585000},"page":"536-543","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A comparative analysis of osteoporosis, nephrolithiasis, and metabolic\/cardiovascular comorbidities in normocalcemic and mild primary hyperparathyroidism"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5975-7786","authenticated-orcid":false,"given":"Mazhar M\u00fcsl\u00fcm","family":"Tuna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130smail","family":"Engin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zden","family":"Uzun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevde Nur","family":"F\u0131rat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zge","family":"Kimyon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif","family":"G\u00fcne\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kadircan","family":"Karatoprak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00dcmit Nur","family":"\u00d6zbay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziynet Alphan","family":"\u00dc\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Ye\u015filtepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u015eevkican","family":"G\u00fcne\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayid Shafi","family":"Zuhur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00fcseyin","family":"Ya\u011fc\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evin","family":"Bozkur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zen \u00d6z","family":"G\u00fcl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayten","family":"O\u011fuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cevdet","family":"Duran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bar\u0131\u015f G\u00fcven","family":"Cansu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurdan","family":"G\u00fcl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,9]]},"reference":[{"key":"1732_CR1","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/j.1365-2265.2008.03520.x","volume":"71","author":"N Yu","year":"2009","unstructured":"Yu N, Donnan PT, Murphy MJ, Leese GP (2009) Epidemiology of primary hyperparathyroidism in Tayside, Scotland, UK. Clin Endocrinol 71:485\u2013493","journal-title":"Clin Endocrinol"},{"key":"1732_CR2","first-page":"18","volume":"17","author":"S Adami","year":"2002","unstructured":"Adami S, Marcocci C, Gatti D (2002) Epidemiology of primary hyperparathyroidism in Europe. J Bone Miner Res 17:18\u201323","journal-title":"J Bone Miner Res"},{"key":"1732_CR3","doi-asserted-by":"publisher","first-page":"666","DOI":"10.20945\/2359-3997000000556","volume":"66","author":"NE Cusano","year":"2022","unstructured":"Cusano NE, Cetani F (2022) Normocalcemic primary hyperparathyroidism. Arch Endocrinol Metab 66:666\u2013677","journal-title":"Arch Endocrinol Metab"},{"key":"1732_CR4","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1210\/jc.2008-1760","volume":"94","author":"SJ Silverberg","year":"2009","unstructured":"Silverberg SJ, Lewiecki EM, Mosekilde L, Peacock M, Rubin MR (2009) Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab 94:351\u2013365","journal-title":"J Clin Endocrinol Metab"},{"key":"1732_CR5","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1210\/jc.2014-1413","volume":"99","author":"JP Bilezikian","year":"2014","unstructured":"Bilezikian JP, Brandi ML, Eastell R, Silverberg SJ, Udelsman R et al (2014) Consensus statement: guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the fourth international workshop. J Clin Endocrinol Metab 99:3561","journal-title":"J Clin Endocrinol Metab"},{"key":"1732_CR6","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2022.37.e99","author":"HR Choi","year":"2022","unstructured":"Choi HR, Choi SH, Hong N, Rhee Y, Kim JK et al (2022) Comparisons between normocalcemic primary hyperparathyroidism and typical primary hyperparathyroidism. J Korean Med Sci. https:\/\/doi.org\/10.3346\/jkms.2022.37.e99","journal-title":"J Korean Med Sci"},{"key":"1732_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2024.115812","volume":"235","author":"C Wu","year":"2024","unstructured":"Wu C, Gillis A, Lindeman B, Chen H, Fazendin J (2024) Normocalcemic primary hyperparathyroidism: from pathophysiology to clinical management. Am J Surg 235:115812","journal-title":"Am J Surg"},{"key":"1732_CR8","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1210\/jc.2011-0238","volume":"96","author":"P Farahnak","year":"2011","unstructured":"Farahnak P, Larfars G, Sten-Linder M, Nilsson IL (2011) Mild primary hyperparathyroidism: 25-OH vitamin D deficiency and cardiovascular risk markers. J Clin Endocrinol Metab 96:2112\u20132118","journal-title":"J Clin Endocrinol Metab"},{"key":"1732_CR9","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1097\/SLA.0b013e31825ffbe1","volume":"257","author":"H Mazeh","year":"2013","unstructured":"Mazeh H, Chen H, Leverson G, Sippel RS (2013) Creation of a \u201cWisconsin index\u201d nomogram to predict the likelihood of additional hyperfunctioning parathyroid glands during parathyroidectomy. Ann Surg 257:138\u2013141","journal-title":"Ann Surg"},{"key":"1732_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12902-019-0487-8","volume":"20","author":"Y Guo","year":"2020","unstructured":"Guo Y, Wang Q, Lu C, Fan P, Li J et al (2020) New parathyroid function index for the differentiation of primary and secondary hyperparathyroidism: a case-control study. BMC Endocr Disord 20:1\u20135","journal-title":"BMC Endocr Disord"},{"key":"1732_CR11","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1210\/jc.2010-2704","volume":"96","author":"AC Ross","year":"2011","unstructured":"Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM et al (2011) The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 96:53\u201358","journal-title":"J Clin Endocrinol Metab"},{"key":"1732_CR12","doi-asserted-by":"publisher","first-page":"R33","DOI":"10.1530\/EJE-21-1044","volume":"186","author":"J Bollerslev","year":"2022","unstructured":"Bollerslev J, Rejnmark L, Zahn A, Heck A, Appelman-Dijkstra NM et al (2022) European expert consensus on practical management of specific aspects of parathyroid disorders in adults and in pregnancy: recommendations of the ESE Educational Program of Parathyroid Disorders (PARAT 2021). Eur J Endocrinol 186:R33\u2013R63","journal-title":"Eur J Endocrinol"},{"key":"1732_CR13","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1590\/S0004-27302010000200004","volume":"54","author":"JP Bilezikian","year":"2010","unstructured":"Bilezikian JP, Silverberg SJ (2010) Normocalcemic primary hyperparathyroidism. Arquivos Brasileiros de Endocrinologia & Metabologia 54:106\u2013109","journal-title":"Arquivos Brasileiros de Endocrinologia & Metabologia"},{"key":"1732_CR14","doi-asserted-by":"publisher","first-page":"5348","DOI":"10.1210\/jc.2003-031014","volume":"88","author":"SJ Silverberg","year":"2003","unstructured":"Silverberg SJ, Bilezikian JP (2003) \u201cIncipient\u201d primary hyperparathyroidism: a \u201cforme fruste\u201d of an old disease. J Clin Endocrinol Metab 88:5348\u20135352","journal-title":"J Clin Endocrinol Metab"},{"key":"1732_CR15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jocd.2012.12.001","volume":"16","author":"NE Cusano","year":"2013","unstructured":"Cusano NE, Silverberg SJ, Bilezikian JP (2013) Normocalcemic primary hyperparathyroidism. J Clin Densitom 16:33\u201339","journal-title":"J Clin Densitom"},{"key":"1732_CR16","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1001\/jama.2017.1620","volume":"317","author":"MJ Campbell","year":"2017","unstructured":"Campbell MJ (2017) The definitive management of primary hyperparathyroidism: who needs an operation? JAMA 317:1167\u20131168","journal-title":"JAMA"},{"key":"1732_CR17","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00774-015-0673-3","volume":"34","author":"MM Tuna","year":"2016","unstructured":"Tuna MM, \u00c7al\u0131\u015fkan M, \u00dcnal M, Demirci T, Do\u011fan BA et al (2016) Normocalcemic hyperparathyroidism is associated with complications similar to those of hypercalcemic hyperparathyroidism. J Bone Miner Metab 34:331\u2013335","journal-title":"J Bone Miner Metab"},{"key":"1732_CR18","volume":"4","author":"G Zavatta","year":"2020","unstructured":"Zavatta G, Clarke BL (2020) Normocalcemic hyperparathyroidism: a heterogeneous disorder often misdiagnosed? Journal of Bone and Mineral Research Plus 4:e10391","journal-title":"Journal of Bone and Mineral Research Plus"},{"key":"1732_CR19","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1210\/jc.2013-1300","volume":"98","author":"NE Cusano","year":"2013","unstructured":"Cusano NE, Maalouf NM, Wang PY et al (2013) Normocalcemic hyperparathyroidism and hypoparathyroidism in two community-based nonreferral populations. J Clin Endocrinol Metab 98:2734\u20132741","journal-title":"J Clin Endocrinol Metab"},{"key":"1732_CR20","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.beem.2018.09.009","volume":"32","author":"NE Cusano","year":"2018","unstructured":"Cusano NE, Cipriani C, Bilezikian JP (2018) Management of normocalcemic primary hyperparathyroidism. Best Pract Res Clin Endocrinol Metab 32:837\u2013845","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1732_CR21","doi-asserted-by":"publisher","first-page":"294","DOI":"10.4158\/EP15704.OR","volume":"22","author":"H \u0160iprov\u00e1","year":"2016","unstructured":"\u0160iprov\u00e1 H, Fry\u0161\u00e1k Z, Sou\u010dek M (2016) Primary hyperparathyroidism, with a focus on management of the normocalcemic form: to treat or not to treat? Endocr Pract 22:294\u2013301","journal-title":"Endocr Pract"},{"key":"1732_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-024-03768-6","author":"I Yankova","year":"2024","unstructured":"Yankova I, Lilova L, Petrova D, Dimitrova I, Stoynova M et al (2024) Biochemical characteristics and clinical manifestation of normocalcemic primary hyperparathyroidism. Endocrine. https:\/\/doi.org\/10.1007\/s12020-024-03768-6","journal-title":"Endocrine"},{"key":"1732_CR23","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.surg.2022.05.042","volume":"173","author":"VL Armstrong","year":"2023","unstructured":"Armstrong VL, Hangge PT, Butterfield R, Norain A, Wasif N et al (2023) Phenotypes of primary hyperparathyroidism: does parathyroidectomy improve clinical outcomes for all? Surgery 173:173\u2013179","journal-title":"Surgery"},{"key":"1732_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2020.115583","volume":"141","author":"L Voss","year":"2020","unstructured":"Voss L, N\u00f3brega M, Bandeira L, Griz L, Rocha-Filho PAS, Bandeira F (2020) Impaired physical function and evaluation of quality of life in normocalcemic and hypercalcemic primary hyperparathyroidism. Bone 141:115583","journal-title":"Bone"},{"key":"1732_CR25","doi-asserted-by":"publisher","DOI":"10.5505\/amj.2022.82231","author":"\u015e Polat","year":"2022","unstructured":"Polat \u015e (2022) Normocalcemic primary hyperparathyroidism is not as innocent as it sounds. Ankara Med J. https:\/\/doi.org\/10.5505\/amj.2022.82231","journal-title":"Ankara Med J"},{"key":"1732_CR26","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/01.hjr.0000114706.27531.01","volume":"11","author":"E Kamycheva","year":"2004","unstructured":"Kamycheva E, Sundsfjord J, Jorde R (2004) Serum parathyroid hormone levels predict coronary heart disease: the Troms\u00f8 Study. Eur J Cardiovasc Prev Rehabil 11:69\u201374","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"1732_CR27","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1161\/CIRCULATIONAHA.108.808733","volume":"119","author":"E Hagstr\u00f6m","year":"2009","unstructured":"Hagstr\u00f6m E, Hellman P, Larsson TE, Ingelsson E, Berglund L et al (2009) Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation 119:2765\u20132771","journal-title":"Circulation"},{"key":"1732_CR28","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1161\/CIRCRESAHA.118.313236","volume":"124","author":"A Benetos","year":"2019","unstructured":"Benetos A, Petrovic M, Strandberg T (2019) Hypertension management in older and frail older patients. Circ Res 124:1045\u20131060","journal-title":"Circ Res"},{"key":"1732_CR29","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.2337\/db11-1300","volume":"61","author":"N Barzilai","year":"2012","unstructured":"Barzilai N, Huffman DM, Muzumdar RH, Bartke A (2012) The critical role of metabolic pathways in aging. Diabetes 61:1315\u20131322","journal-title":"Diabetes"},{"key":"1732_CR30","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/0002-9343(88)90397-X","volume":"85","author":"B Draznin","year":"1988","unstructured":"Draznin B (1988) Intracellular calcium, insulin secretion, and action. Am J Med 85:44\u201358","journal-title":"Am J Med"},{"key":"1732_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.719165","volume":"29","author":"Y Hua","year":"2021","unstructured":"Hua Y, Liu HL, Sun JY, Kong XQ, Sun W, Xiong YQ (2021) Association Between Serum Calcium and the Prevalence of Hypertension Among US Adults. Front Cardiovasc Med 29:719165","journal-title":"Front Cardiovasc Med"},{"key":"1732_CR32","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.3945\/ajcn.115.130021","volume":"104","author":"MR Rooney","year":"2016","unstructured":"Rooney MR, Pankow JS, Sibley SD, Selvin E, Reis JP et al (2016) Serum calcium and incident type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) study. Am J Clin Nutr 104:1023\u20131029","journal-title":"Am J Clin Nutr"},{"key":"1732_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12872-019-1093-4","volume":"19","author":"S Beysel","year":"2019","unstructured":"Beysel S, Caliskan M, Kizilgul M, Apaydin M, Kan S et al (2019) Parathyroidectomy improves cardiovascular risk factors in normocalcemic and hypercalcemic primary hyperparathyroidism. BMC Cardiovasc Disord 19:1\u20138","journal-title":"BMC Cardiovasc Disord"},{"key":"1732_CR34","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1007\/s40618-019-01075-w","volume":"42","author":"N Yalla","year":"2019","unstructured":"Yalla N, Bobba G, Guo G, Stankiewicz A, Ostlund R (2019) Parathyroid hormone reference ranges in healthy individuals classified by vitamin D status. J Endocrinol Invest 42:1353\u20131360","journal-title":"J Endocrinol Invest"},{"key":"1732_CR35","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.ando.2015.03.005","volume":"76","author":"JC Souberbielle","year":"2015","unstructured":"Souberbielle JC, Cavalier E, Cormier C (2015) How to manage an isolated elevated PTH? Ann Endocrinol (Paris) 76:134\u2013141","journal-title":"Ann Endocrinol (Paris)"},{"key":"1732_CR36","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00774-010-0200-5","volume":"29","author":"R Okazaki","year":"2011","unstructured":"Okazaki R, Sugimoto T, Kaji H, Fujii Y, Shiraki M et al (2011) Vitamin D insufficiency is defined by serum 25-hydroxyvitamin D and parathyroid hormone before and after oral vitamin D3 load in Japanese subjects. J Bone Miner Metab 29:103\u2013110","journal-title":"J Bone Miner Metab"},{"key":"1732_CR37","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.archger.2007.12.005","volume":"48","author":"M Bj\u00f6rkman","year":"2009","unstructured":"Bj\u00f6rkman M, Sorva A, Tilvis R (2009) Responses of parathyroid hormone to vitamin D supplementation: a systematic review of clinical trials. Arch Gerontol Geriatr 48:160\u2013166","journal-title":"Arch Gerontol Geriatr"},{"key":"1732_CR38","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1002\/jbmr.2536","volume":"30","author":"G El\u2010Hajj Fuleihan","year":"2015","unstructured":"El\u2010Hajj Fuleihan G, Bouillon R, Clarke B, Chakhtoura M, Cooper C et al (2015) Serum 25\u2010hydroxyvitamin D levels: variability, knowledge gaps, and the concept of a desirable range. J Bone Miner Res 30:1119\u20131133","journal-title":"J Bone Miner Res"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-026-01732-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00774-026-01732-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-026-01732-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T17:02:01Z","timestamp":1786640521000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00774-026-01732-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,9]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["1732"],"URL":"https:\/\/doi.org\/10.1007\/s00774-026-01732-0","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,9]]},"assertion":[{"value":"13 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that there are no conflicts of interest that could be perceived as prejudicing the impartiality of the research reported.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}